K-numberK250032
Device nameMarquee™ Disposable Core Biopsy Instrument and Instrument Kit
ApplicantBard Peripheral Vascular, Inc.
Product codeKNW
Device classClass II
Decision dateJul 10, 2025
DecisionSubstantially Equivalent
Regulation876.1075
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Marquee Disposable Core Biopsy Instrument and Kit is a single-use core biopsy device used to obtain tissue samples from soft tissues including breast, liver, kidney, prostate, spleen, lymph nodes, and soft tissue tumors. It comes in multiple needle gauge sizes (12G, 14G, 16G, 18G, 20G) with color-coded cannula releases and is available as a standalone instrument or as a kit with a compatible disposable coaxial biopsy needle.

Technological characteristics

The Marquee shares the same intended use, patient population, principle of operation, duration of use, sterility assurance level, and sterilization method as its predicates. Differences include new labeling modifications to the Indications for Use statement, design changes to the patient/use interface, needle length, sample notch length and penetration depth, material changes with addition of colorants, additional performance specifications, and the addition of a Convenience Kit option.

Test standards cited

ISO 10993-1:2018 for biocompatibility testing, which included cytotoxicity, sensitization, intracutaneous reactivity, acute system toxicity, and material mediated pyrogenicity assays.

Substantial equivalence argument

Substantial equivalence is supported by identical intended use and similar indications for use, patient population, and principle of operation as the predicate devices (Bard Monopty and Bard Mission). Performance testing demonstrated comparable safety and effectiveness through in vitro testing of penetration depths, tensile strength, needle protection, sterile barrier integrity, and shelf life. Ex-vivo porcine tissue testing confirmed sample quality comparable to predicates, and a systematic literature review supported the breast biopsy indication. The design and material changes do not alter the fundamental function or safety profile of the device.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →